[Auditory brain stem evoked potentials in the evaluation of chronic fatigue syndrome].
Bianchedi, M, Croce, A, Moretti, A et al. · Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 1995
Quick Summary
Researchers tested a special hearing test on people with ME/CFS to see if it could find differences in how their brainstem (the lower part of the brain) processes sound. They used two types of sound frequencies—slow and fast clicking sounds—while measuring brain electrical activity. The fast clicking test found unusual patterns in about 64% of people with confirmed ME/CFS, but not in people without ME/CFS, suggesting this test might help identify the condition.
Why It Matters
This study offers potential objective neurophysiological biomarker for ME/CFS diagnosis—a condition lacking validated laboratory tests. If confirmed in larger studies, high-frequency ABR could help clinicians objectively identify CFS and distinguish it from other fatigue-related conditions, improving diagnostic accuracy and reducing diagnostic delay.
Observed Findings
High-frequency ABR (51–71 pps) revealed abnormalities in 7 of 11 CFS patients (64%), statistically significant compared to controls (P = 0.009)
Wave I absence occurred in 2 CFS patients and may indicate cochlear dysfunction
Wave latency delays (wave gaps) were detected in 5 CFS patients
Low-frequency ABR (11 pps) did not discriminate CFS patients from controls
No significant ABR abnormalities were found in 7 non-CFS control subjects (P = 0.920)
Inferred Conclusions
High-frequency auditory brainstem stimulation may be more sensitive than low-frequency stimulation for detecting neurophysiological abnormalities in CFS
ABR abnormalities, particularly wave I absence, may reflect a disorder of the cochlear synapse or inner ear neurotransmission
Combined clinical and high-frequency ABR testing may improve diagnostic reliability in "true" CFS (CDC-defined cases)
Neurophysiological abnormalities appear to be more frequent in clinically confirmed CFS than in suspected or atypical cases
Remaining Questions
Does high-frequency ABR abnormality persist over time, or does it fluctuate with symptom severity?
What This Study Does Not Prove
This study does not establish that ABR abnormalities cause ME/CFS symptoms, only that they may be associated with the condition. The small sample size (11 CFS cases) and lack of detailed clinical correlation limit conclusions about test reliability for clinical diagnosis. No follow-up data were provided to determine whether these abnormalities are stable biomarkers or change over time.
Tags
Symptom:Fatigue
Biomarker:Neuroimaging
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →